Literature DB >> 24477642

Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Emily M Parodi1, Bernhard Kuhn.   

Abstract

Heterocellular communication in the heart is an important mechanism for matching circulatory demands with cardiac structure and function, and neuregulins (Nrgs) play an important role in transducing this signal between the hearts' vasculature and musculature. Here, we review the current knowledge regarding Nrgs, explaining their roles in transducing signals between the heart's microvasculature and cardiomyocytes. We highlight intriguing areas being investigated for developing new, Nrg-mediated strategies to heal the heart in acquired and congenital heart diseases, and note avenues for future research.

Entities:  

Keywords:  ErbB; Heart; Heterocellular communication; Neuregulin

Mesh:

Substances:

Year:  2014        PMID: 24477642      PMCID: PMC3989448          DOI: 10.1093/cvr/cvu021

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  154 in total

1.  Programmed cell death in the developing heart: regulation by BMP4 and FGF2.

Authors:  Z Zhao; S A Rivkees
Journal:  Dev Dyn       Date:  2000-04       Impact factor: 3.780

2.  Ligand discrimination in signaling through an ErbB4 receptor homodimer.

Authors:  C Sweeney; C Lai; D J Riese; A J Diamonti; L C Cantley; K L Carraway
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

3.  Nrg1 reverse signaling in cortical pyramidal neurons.

Authors:  Sandra Peregrin Pedrique; Pietro Fazzari
Journal:  J Neurosci       Date:  2010-11-10       Impact factor: 6.167

4.  Neuregulin-1 and human epidermal growth factor receptors 2 and 3 play a role in human lung development in vitro.

Authors:  N V Patel; M J Acarregui; J M Snyder; J M Klein; M X Sliwkowski; J A Kern
Journal:  Am J Respir Cell Mol Biol       Date:  2000-04       Impact factor: 6.914

5.  Neuregulin in cardiac hypertrophy in rats with aortic stenosis. Differential expression of erbB2 and erbB4 receptors.

Authors:  S Rohrbach; X Yan; E O Weinberg; F Hasan; J Bartunek; M A Marchionni; B H Lorell
Journal:  Circulation       Date:  1999-07-27       Impact factor: 29.690

6.  Neuregulin-1 promotes formation of the murine cardiac conduction system.

Authors:  Stacey Rentschler; Jennifer Zander; Kathleen Meyers; David France; Rebecca Levine; George Porter; Scott A Rivkees; Gregory E Morley; Glenn I Fishman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

7.  Neuregulin-1 protects against doxorubicin-induced apoptosis in cardiomyocytes through an Akt-dependent pathway.

Authors:  T An; Y Zhang; Y Huang; R Zhang; S Yin; X Guo; Y Wang; C Zou; B Wei; R Lv; Q Zhou; J Zhang
Journal:  Physiol Res       Date:  2013-04-16       Impact factor: 1.881

8.  Prevalence, prospective risk markers, and prognosis associated with the presence of left ventricular diastolic dysfunction in young adults: the coronary artery risk development in young adults study.

Authors:  Chintan S Desai; Laura A Colangelo; Kiang Liu; David R Jacobs; Nakela L Cook; Donald M Lloyd-Jones; Kofo O Ogunyankin
Journal:  Am J Epidemiol       Date:  2012-12-04       Impact factor: 4.897

9.  ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.

Authors:  Mitchell B Berger; Jeannine M Mendrola; Mark A Lemmon
Journal:  FEBS Lett       Date:  2004-07-02       Impact factor: 4.124

10.  Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats.

Authors:  Bingong Li; Jian Xiao; Yong Li; Jian Zhang; Minghui Zeng
Journal:  Exp Ther Med       Date:  2013-08-27       Impact factor: 2.447

View more
  27 in total

1.  Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Stuart Walsh; Sangita Choudhury; Niyatie Ammanamanchi; David G Bennett; Cristobal G dos Remedios; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 2.  The epicardium as a hub for heart regeneration.

Authors:  Jingli Cao; Kenneth D Poss
Journal:  Nat Rev Cardiol       Date:  2018-10       Impact factor: 32.419

Review 3.  Mechanisms of Cardiomyocyte Proliferation and Differentiation in Development and Regeneration.

Authors:  Jessie Wettig Yester; Bernhard Kühn
Journal:  Curr Cardiol Rep       Date:  2017-02       Impact factor: 2.931

Review 4.  Zebrafish heart regeneration: Factors that stimulate cardiomyocyte proliferation.

Authors:  D A Zuppo; M Tsang
Journal:  Semin Cell Dev Biol       Date:  2019-09-25       Impact factor: 7.727

Review 5.  Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors:  Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal:  Nat Rev Clin Oncol       Date:  2015-10-13       Impact factor: 66.675

Review 6.  Molecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes.

Authors:  Manasi S Shah; Michael Brownlee
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

7.  Gonadotropin-Dependent Neuregulin-1 Signaling Regulates Female Rat Ovarian Granulosa Cell Survival.

Authors:  Indrajit Chowdhury; Alicia Branch; Sharifeh Mehrabi; Byron D Ford; Winston E Thompson
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

Review 8.  Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening.

Authors:  Yosuke K Kurokawa; Steven C George
Journal:  Adv Drug Deliv Rev       Date:  2015-07-23       Impact factor: 15.470

Review 9.  Molecular mechanisms of heart regeneration.

Authors:  Ana Vujic; Niranjana Natarajan; Richard T Lee
Journal:  Semin Cell Dev Biol       Date:  2019-10-04       Impact factor: 7.727

Review 10.  Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy.

Authors:  Andrea Wan; Brian Rodrigues
Journal:  Cardiovasc Res       Date:  2016-06-10       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.